Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2
The DOI matches its Crossref record.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTNucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2Jerome P. Horwitz, Jonathan Chua, and Michael NoelCite this: J. Org. Chem. 1964, 29, 7, 2076–2078Publication Date (Print):July 1, 1964Publication History Published online1 May 2002Published inissue 1 July 1964https://pubs.acs.org/doi/10.1021/jo01030a546https://doi.org/10.1021/jo01030a546research-articleACS PublicationsRequest reuse permissionsArticle Views1438Altmetric-Citations300LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first successful drug to treat AIDS patients was azidothymidine (AZT), an RT inhibitor, which was first used in 1987.”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [107]
In the citing paper
“AZT is a chain-terminating thymidine analog (107) that was first synthesized as an antibacterial drug but failed in that capacity and was languishing in the chemical archives of Burroughs-Wellcome.”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [107]
Citations
Cites
Still being checked.
Cited by
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Molecular Targets for AIDS Therapy
Mitsuya, H., Yarchoan, R., & Broder, S. (1990) · Science · doi:10.1126/science.1699273 · Cited by 732
Seley-Radtke, K. L., & Yates, M. K. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.04.004 · Cited by 543
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Broder, S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.002 · Cited by 520
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Yates, M. K., & Seley-Radtke, K. L. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2018.11.016 · Cited by 275
Witvrouw, M., Pannecouque, C., Switzer, W. M., Folks, T. M., Clercq, E. D., & Heneine, W. (2004) · Antiviral Therapy · doi:10.1177/135965350400900115 · Cited by 271
Marine compounds and their antiviral activities
Yasuhara-Bell, J., & Lu, Y. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.03.009 · Cited by 245
Yarchoan, R., & Broder, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160925 · Cited by 250
Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidine
Ruprecht, R. M., O'Brien, L. G., Rossoni, L. D., & Nusinoff-Lehrman, S. (1986) · Nature · doi:10.1038/323467a0 · Cited by 238
Drug repositioning: Progress and challenges in drug discovery for various diseases
Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232
Medicinal Chemistry in the Golden Age of Biology: Lessons from Steroid and Peptide Research
Hirschmann, R. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199112781 · Cited by 228
Balzarini, J., Baba, M., Pauwels, R., Herdewijn, P., & De Clercq, E. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90049-4 · Cited by 191
Isobe, H., Fujino, T., Yamazaki, N., Guillot-Nieckowski, M., & Nakamura, E. (2008) · Organic Letters · doi:10.1021/ol801230k · Cited by 182
Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus
Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., & Vandeputte, M. (1987) · Journal of Virological Methods · doi:10.1016/0166-0934(87)90002-4 · Cited by 186
Balzarini, J., Pauwels, R., Baba, M., Herdewijn, P., de Clercq, E., Broder, S., & Johns, D. G. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90178-5 · Cited by 185
A Critical Appraisal of the Evolution of N-Nitrosoureas as Anticancer Drugs
Gnewuch, C. T., & Sosnovsky, G. (1997) · Chemical Reviews · doi:10.1021/cr941192h · Cited by 176
Goethals, O., Clayton, R., Van Ginderen, M., Vereycken, I., Wagemans, E., Geluykens, P., Dockx, K., Strijbos, R., Smits, V., Vos, A., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00470-08 · Cited by 168
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives
Balzarini, J. (1994) · Pharmacy World & Science · doi:10.1007/bf01880662 · Cited by 172
Witvrouw, M., Fikkert, V., Pluymers, W., Matthews, B., Mardel, K., Schols, D., Raff, J., Debyser, Z., De Clercq, E., Holan, G., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12484-4 · Cited by 168
Therapy for Human Immunodeficiency Virus Infection
Wood, A. J. J., Hirsch, M. S., & D'Aquila, R. T. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306103282307 · Cited by 163
Azidonucleosides: Synthesis, Reactions, and Biological Properties
Pathak, T. (2002) · Chemical Reviews · doi:10.1021/cr0104532 · Cited by 160
McLeod, G. X., & Hammer, S. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-487 · Cited by 182
de Souza, D., Mariano, D. O. C., Nedel, F., Schultze, E., Campos, V. F., Seixas, F. K., da Silva, R. S., München, T. S., Ilha, V., Dornelles, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5015296 · Cited by 137
Aoki, S., & Kimura, E. (2000) · Journal of the American Chemical Society · doi:10.1021/ja994537s · Cited by 119
Pluymers, W., Neamati, N., Pannecouque, C. C., Fikkert, V., Marchand, C., Burke, T. R., Pommier, Y. G., Schols, D., Clercq, E. D., Debyser, Z., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12431-5 · Cited by 112
Yang, S. S., Cragg, G. M. L., Newman, D. J., & Bader, J. P. (2001) · Journal of Natural Products · doi:10.1021/np0003995 · Cited by 110
Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
Raveh, A., Delekta, P. C., Dobry, C. J., Peng, W., Schultz, P. J., Blakely, P. K., Tai, A. W., Matainaho, T. K., Irani, D. N., Sherman, D. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082318 · Cited by 118
Lin, T., Sohinazi, R. F., Chen, M. S., Kinney-Thomas, E., & Prusoff, W. H. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90287-5 · Cited by 101
Developmental therapeutics and the acquired immunodeficiency syndrome.
Devita, V., Broder, S., Fauci, A., Kovacs, J. A., & Chabner, B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-568 · Cited by 91
Uracils: Versatile Starting Materials in Heterocyclic Synthesis
Wamhoff, H., Dzenis, J., & Hirota, K. (1992) · Advances in heterocyclic chemistry · doi:10.1016/s0065-2725(08)60222-6 · Cited by 100
Witvrouw, M., Fikkert, V., Hantson, A., Pannecouque, C. C., O’Keefe, B. R., McMahon, J. B., Stamatatos, L., Clercq, E. D., & Bolmstedt, A. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7777-7784.2005 · Cited by 98
Fikkert, V., Maele, B. V., Vercammen, J., Hantson, A., Remoortel, B. V., Michiels, M., Gurnari, C., Pannecouque, C. C., Maeyer, M. D., Engelborghs, Y., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11459-11470.2003 · Cited by 104
Nasr, M., Litterst, C. L., & McGowan, J. J. (1990) · Antiviral Research · doi:10.1016/0166-3542(90)90030-b · Cited by 100
Vaerenbergh, K. V., Laethem, K. V., Albert, J., Boucher, C. A., Clotet, B., Floridia, M., Gerstoft, J., Hejdeman, B., Nielsen, C. H., Pannecouque, C. C., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2109-2117.2000 · Cited by 94
Sommadossi, J., CARLISLE, R., Schinazi, R. F., & Zhou, Z. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.997 · Cited by 87
Slusher, J. T., Kuwahara, S. K., Hamzeh, F. M., Lewis, L. D., Kornhauser, D. M., & Lietman, P. S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2473 · Cited by 81
Fikkert, V., Hombrouck, A., Remoortel, B. V., Maeyer, M. D., Pannecouque, C. C., Clercq, E. D., Debyser, Z., & Witvrouw, M. (2004) · AIDS · doi:10.1097/00002030-200410210-00006 · Cited by 84
Fleet, G. W. J., Son, J. C., & Derome, A. E. (1988) · Tetrahedron · doi:10.1016/s0040-4020(01)85850-6 · Cited by 77
Sharpe, A. H., Jaenisch, R., & Ruprecht, R. M. (1987) · Science · doi:10.1126/science.3037694 · Cited by 74
The Discovery of Reverse Transcriptase
Coffin, J. M., & Fan, H. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-035556 · Cited by 71
“Viologen” Dendrimers as Antiviral Agents: The Effect of Charge Number and Distance
Asaftei, S., & Clercq, E. D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100093p · Cited by 70
HIV nucleoside reverse transcriptase inhibitors
Amblard, F., Patel, D. J., Michailidis, E., Coats, S. J., Kasthuri, M., Biteau, N., Tber, Z., Ehteshami, M., & Schinazi, R. F. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114554 · Cited by 67
Goethals, O., Vos, A., Van Ginderen, M., Geluykens, P., Smits, V., Schols, D., Hertogs, K., & Clayton, R. (2010) · Virology · doi:10.1016/j.virol.2010.03.034 · Cited by 64
Fang, J., & Beland, F. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp136 · Cited by 66
Yoshida, Y., Honma, M., Kimura, Y., & Abe, H. (2020) · ChemMedChem · doi:10.1002/cmdc.202000695 · Cited by 64
Reynolds, C., de Koning, C. B., Pelly, S. C., van Otterlo, W. A. L., & Bode, M. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35058k · Cited by 64
Vardanyan, R., & Hruby, V. J. (2006) · Elsevier eBooks · doi:10.1016/b978-044452166-8/50036-4 · Cited by 63
Sato, K., Seio, K., & Sekine, M. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027131f · Cited by 62
3 The Medicinal Chemistry of the Azido Group
Griffin, R. J. (1994) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70020-1 · Cited by 81
Iyer, V. V., Griesgraber, G. W., Radmer, M. R., McIntee, E. J., & Wagner, C. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000110g · Cited by 61
Martin, J. C., Hitchcock, M. J. M., Clercq, E. D., & Prusoff, W. H. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.006 · Cited by 69
Sulfonic Esters of Carbohydrates: Part II
Ball, D. H., & Parrish, F. W. (1969) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(08)60350-9 · Cited by 60
Thiol Reduction of 3′-Azidothymidine to 3′-Aminothymidine: Kinetics and Biomedical Implications
Handlon, A. L., & Oppenheimer, N. J. (1988) · Pharmaceutical Research · doi:10.1023/a:1015926720740 · Cited by 58
Chu, C. K., Beach, J. W., Ullas, G. V., & Kosugi, Y. (1988) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)82864-6 · Cited by 58
Hirschmann, R. F. (1991) · Angewandte Chemie · doi:10.1002/ange.19911031008 · Cited by 58
Carbocyclic analogs of nucleosides. Part 2.. Synthesis of 2′,3′‐dideoxy‐5′‐homonucleoside analogs
Jenny, T. F., Horlacher, J., Previsani, N., & Benner, S. A. (1992) · Helvetica Chimica Acta · doi:10.1002/hlca.19920750620 · Cited by 56
Milestones in the discovery of antiviral agents: nucleosides and nucleotides
Clercq, E. D. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.10.001 · Cited by 55
Torrence, P. F., Kinjo, J., Lesiak, K. B., Balzarini, J. M., & Clercq, E. D. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81319-x · Cited by 55
Pharmacokinetics and saturable renal tubular secretion of zidovudine in rats
Patel, B. A., Chu, C. K., & Boudinot, F. D. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780704 · Cited by 54
Framing expectations in early HIV cure research
Dubé, K., Henderson, G. E., & Margolis, D. M. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.08.003 · Cited by 53
Hombrouck, A., Voet, A., Van Remoortel, B., Desadeleer, C., De Maeyer, M., Debyser, Z., & Witvrouw, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00911-07 · Cited by 51
Yarchoan, R., & Broder, S. E. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90083-1 · Cited by 51
Kawaguchi, T., Ishikawa, K., Seki, T., & Juni, K. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790616 · Cited by 49
3′‐(1,2,3‐Triazol‐1‐yl)‐2′,3′‐dideoxythymidine and 3′‐(1,2,3‐triazol‐1‐yl)‐2′,3′‐dideoxyuridine
Wigerinck, P. B. T. P., Aerschot, A. A. V., Claes, P., Balzarini, J. M., Clercq, E. D., & Herdewijn, P. A. (1989) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570260624 · Cited by 49
Competitive inhibitors of human immunodeficiency virus reverse transcriptase
Schinazi, R. F. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171660 · Cited by 50
Hartmann, K. (2015) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x15610676 · Cited by 47
DUESBERG, P. H., Koehnlein, C., & Rasnick, D. (2003) · Journal of Biosciences · doi:10.1007/bf02705115 · Cited by 46
Chemotherapy of Human Immunodeficiency Virus Infections: Current Practice and Future Prospects
Hirsch, M. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.5.845 · Cited by 50
Ono, K., Ogasawara, M., Iwata, Y., Nakane, H., Fujii, T., Sawai, K., & Saneyoshi, M. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90760-6 · Cited by 46
The AIDS dilemma: drug diseases blamed on a passenger virus
DUESBERG, P. H., & Rasnick, D. (1998) · Genetica · doi:10.1023/a:1003405220186 · Cited by 45
Antiviral Therapy in Human Immunodeficiency Virus Infection
Sandström, E. (1989) · Drugs · doi:10.2165/00003495-198938030-00005 · Cited by 46
McGuigan, C., Nicholls, S. R., O'Connor, T. J., & Kinchington, D. (1990) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029000100105 · Cited by 44
Therapeutic Approaches for Zika Virus Infection of the Nervous System
Abrams, R. P. M., Solis, J., & Nath, A. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0575-2 · Cited by 44
Wilson, I. K., Chatterjee, S., & Wolf, W. (1991) · Journal of Fluorine Chemistry · doi:10.1016/s0022-1139(00)82356-8 · Cited by 41
Prusoff, W. H., Chen, M. S., Fischer, P. H., Lin, T., Shiau, G. T., Schinazi, R. F., & Walker, J. (1979) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(79)90023-8 · Cited by 41
The Discovery and Development of Antiretroviral Agents
Lange, J. M. A., & Ananworanich, J. (2013) · Antiviral Therapy · doi:10.3851/imp2896 · Cited by 54
Phytochemical and biological investigations of Elaeodendron schlechteranum
Maregesi, S. M., Hermans, N., Dhooghe, L., Cimanga, K., Ferreira, D., Pannecouque, C. C., Berghe, D. A. V., Cos, P., Maes, L. J. R. M., Vlietinck, A. J., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.03.034 · Cited by 40
Kundu, N. G., & Dasgupta, S. K. (1993) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19930002657 · Cited by 40
Wagner, C. R., Ballato, G., Akanni, A., McIntee, E. J., Larson, R. A., Chang, S. L., & Abul‐Hajj, Y. J. (1997) · PubMed · Cited by 39
Molecular Targets of Antiviral Therapy
Flier, J. S., Underhill, L. H., & Crumpacker, C. S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210306 · Cited by 39
N-Aminoimidazole Derivatives Inhibiting Retroviral Replication via a Yet Unidentified Mode of Action
Lagoja, I. M., Pannecouque, C. C., Aerschot, A. A. V., Witvrouw, M., Debyser, Z., Balzarini, J. M., Herdewijn, P. A., & Clercq, E. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0211117 · Cited by 38
A facile method for deprotection of trityl ethers using column chromatography
Pathak, A. K., Pathak, V., Seitz, L. E., Tiwari, K. N., Akhtar, M. S., & Reynolds, R. C. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)01645-8 · Cited by 38
Fikkert, V., Cherepanov, P., Laethem, K. V., Hantson, A., Remoortel, B. V., Pannecouque, C. C., Clercq, E. D., Debyser, Z., Vandamme, A., & Witvrouw, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3954-3962.2002 · Cited by 38
Parthasarathy, R., & Kim, H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80721-6 · Cited by 36
Barton, D. H. R., Géro, S. D., Quiclet‐Sire, B., & Samadi, M. H. (1989) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)80556-6 · Cited by 36
Kumar, J. M., Idris, M. M., Srinivas, G., Kumar, P. V., Vuppalapaty, M., Kavitha, M., Reddy, C. R., Mainkar, P. S., Pal, B., Chandrasekar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070798 · Cited by 35
Synthesis and characterization of ferrocene-labeled oligodeoxynucleotides
Beilstein, A. E., & Grinstaff, M. W. (2001) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(01)00943-3 · Cited by 35
Goethals, O., Ginderen, M. V., Vos, A. M., Cummings, M. D., der Borght, K. V., Wesenbeeck, L. V., Feyaerts, M., Verheyen, A., Smits, V., Loock, M. V., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.05.011 · Cited by 38
Asai, D., & Nakashima, H. (2018) · Medicines · doi:10.3390/medicines5040120 · Cited by 34
Popoola, T. D., Segun, P. A., Ekuadzi, E., Dickson, R. A., Awotona, O. R., Nahar, L., Sarker, S. D., & Fatokun, A. A. (2022) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-022-00437-9 · Cited by 34
NiFe 2 O 4 /poly(ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery
Joshy, K. S., Augustine, R., Mayeen, A., Alex, S. M., Hasan, A., Thomas, S., & Chi, H. (2020) · New Journal of Chemistry · doi:10.1039/d0nj01163k · Cited by 33
El-Laghdach, A., Díaz, Y., & Castillón, S. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73571-4 · Cited by 33
Bálint, G. S. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00101-7 · Cited by 39
Pharmacokinetic Individualisation of Zidovudine Therapy
Hoetelmans, R. M. W., Burger, D. M., Meenhorst, P. L., & Beijnen, J. H. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00004 · Cited by 32
Hepatic Morphological Alterations Induced by Zidovudine (ZDV) in an Experimental Model
Corcuera, T., Alonso, M. J. M., Picazo, A., Gómez, F., Roldán, M., Abad, M., Muñóz, E., & López-Bravo, A. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80218-4 · Cited by 31
Modica-Napolitano, J. S., Nalbandian, R., Kidd, M. E., Nalbandian, A., & Nguyen, C. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00274-x · Cited by 30
Multistep Continuous Flow Synthesis of Stavudine
Sagandira, C. R., Akwi, F. M., Sagandira, M. B., & Watts, P. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c01013 · Cited by 29
Karp, J. E., Pluda, J. M., & Yarchoan, R. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70383-x · Cited by 29
Skiba, J., Kowalski, K., Próchnicka, A., Ott, I., Solecka, J., Rajnisz, A., & Therrien, B. (2014) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2014.11.017 · Cited by 28
Metadata
- Authors
- Horwitz, J. P., Chua, J., & Noel, M.
- Venue
- The Journal of Organic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1964-07
- Volume
- 29
- Issue
- 7
- Pages
- 2076-2078
- ISSN
- 0022-3263 (ISSN-L)
- 1520-6904
- OpenAlex
- W2330220433
- Cited by
- 348
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 3 · 2022: 11 · 2021: 8 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 7 · 2015: 4 · 2014: 2 · 2013: 9 · 2012: 4
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Organic Chemistry (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nucleosides, thymine, deoxy sugars, nucleoside methylation, sugar nucleosides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.